Advancing the science for active surveillance: Rationale and design for the observational medical outcomes partnership

Annals of Internal Medicine

Volumn 153, Issue 9, 2010, Pages 600-606

  Stang, Paul E ^a   Ryan, Patrick B ^b   Racoosin, Judith A ^c   Overhage, J Marc ^d   Hartzema, Abraham G ^e   Reich, Christian ^b   Welebob, Emily ^b   Scarnecchia, Thomas ^f   Woodcock, Janet ^c  

^a JOHNSON AND JOHNSON   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d REGENSTRIEF INSTITUTE   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

^f Building 51 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER PROGRAM; DATA BASE; DRUG INFORMATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; MEDICAID; MEDICARE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW;

EID: 78751688048     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-9-201011020-00010     Document Type: Review

References (37)

1. Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, et al. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med. 2007;167:1041-9. [PMID: 17533207]
2. Institute of Medicine. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, DC: National Academies Pr; 2006.
3. Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, et al; for the Vaccine Safety Datalink Rapid Cycle Analysis Team. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007;45: S89-95. [PMID: 17909389]
4. Food and Drug Administration Amendments Act of 2007, Pub. L. No. 110-85, § 905.
5. National Council of Public Private Partnerships. How PPPs work. Accessed at www.ncppp.org/howpart/index.shtml on 30 January 2010.
6. Gill JM, Chen YX, Lieberman MI. Management of depression in ambulatory care for patients with medical co-morbidities: a study from a national Electronic Health Record (EHR) network. Int J Psychiatry Med. 2008;38:203-15. [PMID: 18724571]
7. Adamson DM, Chang S, Hansen LG. Health Research Data for the Real World: The MarketScan Databases. White Paper. New York: Thomson Healthcare; January 2008. Accessed at http://home.thomsonhealthcare.com/uploadedFiles/docs/ 2008HealthResearchDatafortheRealWorldThe%20MarketScanDatabases(1).pdf on 15 August 2010.
8. McDonald CJ, Overhage JM, Barnes M, Schadow G, Blevins L, Dexter PR, et al; INPC Management Committee. The Indiana network for patient care: a working local health information infrastructure. An example of a working infrastructure collaboration that links data from five health systems and hundreds of millions of entries. Health Aff (Millwood). 2005;24:1214-20. [PMID: 16162565]
9. Shatin D, Rawson NS, Stergachis A. UnitedHealth Group. In: Strom B, ed. Pharmacoepidemiology. 4th ed. West Sussex, UK: J Wiley; 2005:271-80.
10. Brownstein JS, Murphy SN, Goldfine AB, Grant RW, Sordo M, Gainer V, et al. Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care. 2010;33:526-31. [PMID: 20009093]
11. Palacio A, Uribe CL, Li H, Hanna J, Deminski M, Alvir J, et al. Financial and clinical characteristics of fibromyalgia: a case-control comparison. Am J Manag Care. 2010;16:S118-25. [PMID: 20586520]
12. Pamer CA, Hammad TA, Wu YT, Kaplan S, Rochester G, Governale L, et al. Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions. Pharmacoepidemiol Drug Saf. 2010;19:158-74. [PMID: 20049836]
13. Berlowitz DR, Miller DR, Oliveria SA, Cunningham F, Gomez-Caminero A, Rothendler JA. Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin. Pharmacoepidemiol Drug Saf. 2006;15:799-807. [PMID: 16892457] (Pubitemid 44762711)
14. Curtis JR, Cheng H, Delzell E, Fram D, Kilgore M, Saag K, et al. Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example. Med Care. 2008;46:969-75. [PMID: 18725852]
15. Hochberg AM, Hauben M, Pearson RK, O'Hara DJ, Reisinger SJ, Goldsmith DI, et al. An evaluation of three signal-detection algorithms using a highly inclusive reference event database. Drug Saf. 2009;32:509-25. [PMID: 19459718]
16. Almenoff JS, DuMouchel W, Kindman LA, Yang X, Fram D. Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post-marketing setting. Pharmacoepidemiol Drug Saf. 2003;12:517-21. [PMID: 14513665] (Pubitemid 37069389)
17. Gould AL. Accounting for multiplicity in the evaluation of "signals" obtained by data mining from spontaneous report adverse event databases. Biom J. 2007; 49:151-65. [PMID: 17342957]
18. Norén GN, Bate A, Hopstadius J, Star K, Edwards IR. Temporal pattern discovery for trends and transient effects: its application to patient records. In: Proceedings of the 14th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, Las Vegas, Nevada, 24-27 August 2008. New York: Association for Computing Machinery; 2008.
19. Norén GN, Hopstadius J, Bate A, Star K, Edwards I. Temporal pattern discovery in longitudinal electronic patient records. Data Min Knowl Discov. 2010;20: 361-87.
20. Breslow NE, Day NE. Statistical Methods in Cancer Research. Volume 1: The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer; 1993.
21. Rosenberg L, Coogan PF, Palmer JR. Case-control surveillance. In: Strom B, ed. Pharmacoepidemiology. 4th ed. West Sussex, UK: J Wiley; 2005:185-202.
22. Whitaker HJ, Hocine MN, Farrington CP. The methodology of selfcontrolled case series studies. Stat Methods Med Res. 2009;18:7-26. [PMID: 18562396]
23. Schneeweiss S, Stürmer T, Maclure M. Case-crossover and case-time-control designs as alternatives in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 1997;6 Suppl 3:S51-9. [PMID: 15073755]
24. Ryan PB, Powell GE, Pattishall EN, Beach KJ. Performance of screening multiple observational databases for active drug safety surveillance. Poster Presented at the 25 Annual Meeting of the International Society of Pharmacoepidemiology, Providence, Rhode Island, 16-19 August 2009. Accessed at www.prosanos.com/uploaded/Ryan-ISPE2009-handout-18aug2009.pdf on 19 August 2010.
25. Ryan PB, Powell GE. Exploring candidate differences between drug cohorts prior to exposure: a systematic approach using multiple observational databases. Poster Presented at the 13th International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Toronto, Ontario, Canada, 3-7 May 2008.
26. Janzen WP, ed. High Throughput Screening: Methods and Protocols. 2nd ed. Totowa, NJ: Humana Pr; 2002.
27. Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20:512-22. [PMID: 19487948]
28. Faries D, Leon A, Haro J, Obenchain RL. The local control approach using JMP. In: Analysis of Observational Health Care Data Using SAS. Cary, NC: SAS Pr; 2010.
29. Kulldorff M, Davis R, Kolczak M, Lewis E, Lieu T, Platt R. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Working Paper. Boston: Harvard Medical School Department of Ambulatory Care and Prevention Working Paper; 2007. Accessed at www.populationmedicine.org/content/ docs/maxSPRTsubm.pdf on 9 September 2010.
30. Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, et al. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007; 16:1275-84. [PMID: 17955500]
31. Li L. A conditional sequential sampling procedure for drug safety surveillance. Stat Med. 2009;28:3124-38. [PMID: 19691034]
32. Genkin A, Lewis D, Madigan D. Large-scale Bayesian logistic regression for text categorization. Technometrics. 2007;49:291-304. (Pubitemid 47292487)
33. Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf. 2005;4:929-48. [PMID: 16111454]
34. Davis J, Burnside E, Dutra I, Page D, Ramakrishnan R, Santos Costa V, et al. View learning for statistical relational learning: with an application to mammography. In: Proceedings of the International Joint Conference on Artificial Intelligence, Edinburgh, United Kingdom, 30 July-5August 2005. Menlo Park, CA: International Joint Conference on Artificial Intelligence; 2005:677-83.
35. Burnside ES, Davis J, Chhatwal J, Alagoz O, Lindstrom MJ, Geller BM, et al. Probabilistic computer model developed from clinical data in national mammography database format to classify mammographic findings. Radiology. 2009;251:663-72. [PMID: 19366902]
36. Holbrook A, Grootendorst P, Willison D, Goldsmith C, Sebaldt R, Keshavjee K. Can current electronic systems meet drug safety and effectiveness requirements? AMIA Annu Symp Proc. 2005:335-9. [PMID: 16779057]
37. 42 C.F.R. § 412, § 413, § 422, §495 (2010).